Blood Coagulation Disorders
63
1
1
39
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.8%
3 terminated out of 63 trials
92.9%
+6.4% vs benchmark
27%
17 trials in Phase 3/4
23%
9 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (63)
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Analysis of the Coagulopathy Developed by COVID-19 Infected Patients
Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects
Study Using Plasma for Patients Requiring Emergency Surgery
The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
Thrombin Generation in Liver Transplant Surgery
Kid Cards: Teaching Kids About Medicines
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
Determination of Fibrin Activity in Plasma on STA-R® Prototype
Major Liver Resection: Early Clotting Disorders and Functional Impairment.
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Evaluating URMC's Massive Transfusion Protocol
Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass
Clinical and Economic Implications of Genetic Testing for Warfarin Management
Dental Extractions in Patients Under Dual Antiplatelet Therapy
A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
European Transfusion Practice and Outcome Study
Fibrinogen Concentrate In Children Cardiac Surgery 2
Blood Cell Adhesion to Arterial Filters During Cardiac Surgery